Progress, Obstacles and Prospects in Surgery and Cancer

Burcu Darst^*
*Correspondence: Burcu Darst, Department of Public Health Sciences, University of Southern California, Los Angeles, CA, USA, Email:

Introduction

One of the mainstays of the all-encompassing strategy for treating cancer has traditionally been surgery. It is essential for the diagnosis, staging, and management of many types of cancer. Cancer surgery has been transformed over time by notable improvements in surgical methods, technological developments, and a better comprehension of cancer biology. Nevertheless, these developments provide a distinct set of difficulties and have opened the door to investigating potential future paths that might further alter the cancer treatment landscape.

The accuracy and efficacy of cancer procedures have significantly increased due to advancements in surgical techniques. Laparoscopy and robotic-assisted surgery are two examples of minimally invasive procedures that are becoming more and more popular. Reduced chances of infection, faster recovery periods, less pain, and smaller incisions are all benefits of these operations. In cancer procedures, these methods have greatly enhanced patient outcomes and overall quality of life, particularly for tumors situated in sensitive or difficult-to-reach locations. The discipline of cancer surgery has been influenced by the idea of precision medicine. Surgeons can now customize treatments according to the unique genetic composition of a patient's tumor because to developments in genetic and molecular analysis. Targeted surgeries are made possible by this customized technique, guaranteeing that just the malignant tissues are removed while leaving healthy tissues and organs intact. With precision surgery, collateral damage is reduced [1,2].

Description

Despite the advancements, there are still a number of obstacles facing cancer surgery. The detection and elimination of all malignant cells is a major task. It can be difficult to differentiate between healthy and malignant tissues, even with sophisticated imaging tools, particularly at the microscopic level. Recurrence might result from incomplete removal of malignant cells, highlighting the need for more accurate and focused surgical techniques. Furthermore, a patient's quality of life may be impacted by the degree of tissue removal and the invasiveness of specific surgery. For example, major organ or structure surgeries may cause long-term functional deficits. Surgeons must delicately strike a balance between the need to remove malignant tissues and maintaining organ function and general health [3]. The use of nanotechnology in cancer surgery has enormous potential. Cancer cells can be more easily located and removed after surgery if nanoparticles are designed to target them precisely. Additionally, by delivering tailored medicines straight to cancer cells, these particles can maximize therapy efficacy while reducing adverse effects on healthy organs. The accuracy and results of cancer surgery could be greatly enhanced by combining nanotechnology with surgical techniques.

The combination of Artificial Intelligence (AI) and robotics has the potential to completely transform cancer surgery. AI-guided robotic-assisted operations provide unmatched accuracy and dexterity. Large volumes of medical data can be analyzed by AI systems, which help surgeons with preoperative planning, in-the-moment surgical decision-making, and postoperative care. By improving the surgeon's skills, these technologies guarantee safer and more precise operations. Modern imaging methods including Positron Emission Tomography (PET), Augmented Reality (AR), and Magnetic Resonance Imaging (MRI) give surgeons precise, up-to-date information on the tumor's location, size, and surrounding structures. AR provides a thorough and dynamic perspective of the process by superimposing this information onto the surgeon's field of vision. Surgeons may more confidently handle difficult anatomies because to these technologies' accurate, real-time guidance, which increases accuracy.

Optimizing preoperative, intraoperative, and postoperative care is the main goal of ERAS protocols in order to hasten recovery and reduce complications. A multidisciplinary approach is used in these protocols, which include early mobilization, dietary optimization, and pain treatment. ERAS protocols increase postoperative results, decrease hospital stays, and improve the overall surgical experience for cancer patients by improving the patient's general health and well-being. A key component of the all-encompassing treatment of cancer is surgery. It is frequently used for a number of tasks, such as identifying the stage of cancer, diagnosing it, excising tumors, and occasionally easing symptoms. Surgery and cancer treatment have a complex interaction that includes a variety of surgical procedures, cuttingedge methods, and changing strategies that all work together to combat this complicated illness [4]. Debunking surgery is used to remove a section of the tumor when cancer cannot be totally eliminated. This method is frequently used in advanced cases where eliminating a portion of the tumor might reduce symptoms and increase the efficacy of later therapies like radiation therapy and chemotherapy [5].

Conclusion

Innovation continues to flourish in the nexus of surgery and cancer treatment, where developments, obstacles, and potential paths forward come together. The future of cancer surgery looks brighter as scientists, surgeons, and technologists work together. Cancer surgeries are becoming more efficient and compassionate thanks to personalized precision surgery made possible by nanotechnology, robotics, artificial intelligence, sophisticated imaging, and improved recuperation procedures. The combination of these methods and technologies will probably reshape the cancer surgery standard of care in the years to come. Patients should expect speedier recovery times, less intrusive procedures, better overall quality of life, and more accurate diagnosis. The development of surgical methods is a ray of hope as we negotiate the challenges of cancer.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Luke, Brian, Andrea Panza, Sophie Redon and Nahid Iglesias, et al. "The Rat1p 5′ to 3′ exonuclease degrades telomeric repeat-containing RNA and promotes telomere elongation in S. cerevisiae." Mol cell 32 (2008): 465-477.

Google Scholar, Crossref, Indexed at

2. Clark, B., J. Sitzia and W. Harlow. "Incidence and risk of arm oedema following treatment for breast cancer: A three-year follow-up study." Qjm 98 (2005): 343-348.

Google Scholar, Crossref, Indexed at

3. Olsson Möller, Ulrika, Ingela Beck, L. Rydén and M. Malmström. "A comprehensive approach to rehabilitation interventions following breast cancer treatment-A systematic review of systematic reviews." BMC Cancer 19 (2019): 1-20.

Google Scholar, Crossref, Indexed at

4. Armer, Jane M., M. Elise Radina, Davina Porock and Scott D. Culbertson. "Predicting breast cancer-related lymphedema using self-reported symptoms." Nurs Res 52 (2003): 370-379.

Google Scholar, Crossref, Indexed at

5. Sage, Andrew P. and Ziad Mallat. "Multiple potential roles for B cells in atherosclerosis." Ann Med 46 (2014): 297-303.

Google Scholar, Crossref, Indexed at